Lower rate of initial failures and reduced occurrence of adverse events with a new catheter model for continuous subcutaneous insulin infusion: Prospective, two-period, observational, multicenter study

Diabetes Technology and Therapeutics

Volumn 12, Issue 10, 2010, Pages 769-773

  Renard, Eric ^a,b   Guerci, Bruno ^c   Leguerrier, Anne Marie ^d   Boizel, Robert ^e  

^a LAPEYRONIE HOSPITAL   (France)

^b UNIV MONTPELLIER   (France)

^c Ctr Hospitalier Univ de Nancy   (France)

^d RENNES UNIVERSITY HOSPITAL   (France)

^e Roche Diagnostics France   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

ADULT; ARTICLE; CATHETER COMPLICATION; CATHETERIZATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; DIABETES MELLITUS; DRUG DELIVERY SYSTEM; FEMALE; HUMAN; HYPERGLYCEMIA; INJECTION SITE ERYTHEMA; INJECTION SITE PAIN; INSULIN INFUSION; MALE; MULTICENTER STUDY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; SKIN MANIFESTATION;

ADULT; AGED; BLOOD GLUCOSE; CATHETER-RELATED INFECTIONS; CATHETERIZATION; CATHETERS, INDWELLING; CROSS-OVER STUDIES; DIABETES COMPLICATIONS; DIABETES MELLITUS; HUMANS; HYPERGLYCEMIA; INCIDENCE; INFUSIONS, SUBCUTANEOUS; INSULIN; INSULIN INFUSION SYSTEMS; MALE; MIDDLE AGED;

EID: 77957951120     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/dia.2010.0073     Document Type: Article

References (9)

1. Clausen TS, Kaastrup P, Stallknecht B: Effect of insulin catheter wear-time on subcutaneous adipose tissue blood flow and insulin absorption in humans. Diabetes Technol Ther 2009;11:575-580.
2. Selam JL, Charles MA: Devices for insulin administration. Diabetes Care 1990;13:955-979.
3. Skyler JS, Ponder S, Kruger DF: Is there a place for insulin pump therapy in your practice? Clin Diabetes 2007;25:50-56.
4. CDRH Home Healthcare Committee: Home Healthcare Medical Devices: Infusion Therapy-Getting the Most Out of Your Pump. Updated February 7, 2005. gov/cdrh/cdrhhhc/brochure-infusion.pdf (last accessed April 20, 2010).
5. Weissberg-Benchell J, Antisdel-Lomaglio J, Seshadri R: Insulin pump therapy: a meta-analysis. Diabetes Care 2003;26: 1079-1087.
6. Hoogma RP, Hammond PJ, Gomis R, Kerr D, Bruttomesso D, Bouter KP, Wiefels KJ, de la Calle H, Schweitzer DH, Pfohl M, Torlone E, Krinelke LG, Bolli GB; 5-Nations Study Group: Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH-based multiple daily insulin injections (MDI) on glycaemic control and quality of life: results of the 5-Nations trial. Diabet Med 2005;23:141-147.
7. Hanaire H, Lassmann-Vague V, Jeandidier N, Renard E, Tubiana-Rufi N, Vambergue A, Raccah D, Pinget M, Guerci B: Treatment of diabetes mellitus using an external insulin pump: the state of the art. Diabetes Metab 2008;34:401-423.
8. Pfü tzner J, Forst T, Butzer R, Forst S, Weber MM, Pfü tzner AH, Pfü tzner A: Performance of the continuous glucose monitoring system (CGMS) during development of ketosis in patients on insulin pump therapy. Diabet Med 2006;23:1124-1129.
9. Hfjbjerre L, Skov-Jensen C, Kaastrup P, Pedersen PE, Stallknecht B: Effect of steel and Teflon infusion catheters on subcutaneous adipose tissue blood flow and infusion counter pressure in humans. Diabetes Technol Ther 2009;11:301-306.